FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/05/2022
Voltar para busca
Dado oficial do USPTO
CELLPROTHERA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
30/05/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 42, 44
Data de depósito
01/04/2020
Data de registro
23/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/11/2021
Última transação
23/11/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
FR
Examinador
BELL, MARLENE D
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "CELLPROTHERA" and the letter "O" is completely shaded.
Titulares e representantes
Titulares
CELLPROTHERA
Representantes
Janet G Ricciuti JANET GILBERT RICCIUTI
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Biological preparations for cell culturescell culture mediaculture media for cell growth for medical biotechnologybiological reagents for molecular biologychemical reagents for medical use for biological processescarriers of culture media for medical usecellular function activating agentsserumsantibodiesall these products being for medical use
Classe 10
Medical apparatus and instrumentsmedical devices in the nature of human and animal cellstem cells and cell-derived products and instruments for injection of cellstem cells and cell-derived productschambers for culturecentrifugation and isolation of cellstem cell and cell-derived for cell-based diagnosis and treatment; apparatus for cell culturenamely medical devices for human and animal cell culture diagnosis and treatment; medical instruments for cell culturenamely instruments for cell culture media and for potency testing of human and animal cell and cell-derived products for cell based treatment and diagnostic; medical apparatus and devices for cell separation techniquesmedical device and apparatus for human and animal cell selectionfor human cell immune and for cell dimension selection for the cell-based diagnosis and treatment
Classe 42
Research and development services of new products in the field of biotechnologyscientific analysis services in the field of medical research laboratory services for medical purposes and for development of new products for medical research for third parties
Classe 44
Services for medical care and treatmentnamely therapeutic treatments in the field of cell therapy and regenerative medicine; medical services for cell growthsampling and isolation for the production of cell and cell-derived human and animal cell productscell and stem cell graft injection therapy allowing for the regeneration of damaged tissues following age-related diseases or traumas for medical treatment services; services for medical analysis relating to treating individualsbehavioral analysis for medical purposestherapeutic treatmentnamely cell therapy for regenerative medicine
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/05/2022
FIMP
FINAL DISPOSITION PROCESSED
10/05/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
23/11/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
29/10/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/10/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/10/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2021
PUBO
PUBLISHED FOR OPPOSITION
07/09/2021
GPNX
NOTIFICATION PROCESSED BY IB
04/09/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/08/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/07/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
21/07/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/03/2021
GNFR
FINAL REFUSAL E-MAILED
08/03/2021
CNFR
FINAL REFUSAL WRITTEN
08/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/01/2021
RFNT
REFUSAL PROCESSED BY IB
29/08/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/08/2020
RFRR
REFUSAL PROCESSED BY MPU
04/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/06/2020
CNRT
NON-FINAL ACTION WRITTEN
28/06/2020
DOCK
ASSIGNED TO EXAMINER
21/06/2020
MAFR
APPLICATION FILING RECEIPT MAILED
07/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2020
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
30/04/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLPROTHERA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.